INSM · NASDAQ · Biotechnology

Insmed (INSM)

Commercializes rare pulmonary disease medicines while developing pulmonary, antibody and gene therapies.

$120.82
After hours+0.03 (+0.02%)
At close$120.79(−0.17%)